FENNEC PHARMACEUTICALS INC (FENC) Forecast, Price Target & Analyst Ratings

NASDAQ:FENC • CA31447P1009

Current stock price

6.64 USD
-0.09 (-1.34%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FENNEC PHARMACEUTICALS INC (FENC).

Forecast Snapshot

Consensus Price Target

Price Target
$15.47
+ 132.98% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.01
Revenue Estimate
15.304M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.62%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$15.47
Upside
+ 132.98%
From current price of $6.64 to mean target of $15.47, Based on 13 analyst forecasts
Low
$13.13
Median
$15.81
High
$18.90

Price Target Revisions

1 Month
-1.09%
3 Months
-0.22%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for FENC. The average price target is 15.47 USD. This implies a price increase of 132.98% is expected in the next year compared to the current price of 6.64.
The average price target has been revised downward by 0.22% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

FENC Current Analyst RatingFENC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

FENC Historical Analyst RatingsFENC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.62%
FENC was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about FENC.
In the previous month the buy percentage consensus was at a similar level.
FENC was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-16WedbushReiterate Outperform -> Outperform
2026-01-09Piper SandlerInitiate Overweight
2025-08-21HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-15Craig-HallumMaintains Buy -> Buy
2025-05-20HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-14Craig-HallumMaintains Buy -> Buy
2025-03-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-17HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-22HC Wainwright & Co.Maintains Buy -> Buy
2024-08-14Craig-HallumMaintains Buy -> Buy
2024-05-15Craig-HallumMaintains Buy -> Buy
2024-05-15HC Wainwright & Co.Maintains Buy -> Buy
2024-04-04HC Wainwright & Co.Maintains Buy -> Buy
2024-03-18Craig-HallumMaintains Buy -> Buy
2023-08-04HC Wainwright & Co.Maintains Buy -> Buy
2023-06-21HC Wainwright & Co.Reiterate Buy -> Buy
2023-04-06Cantor FitzgeraldMaintains Overweight
2023-04-04HC Wainwright & Co.Reiterate Buy
2023-03-31HC Wainwright & Co.Reiterate Buy
2023-01-26HC Wainwright & Co.Reiterate Buy
2022-11-22Cantor FitzgeraldUpgrade Neutral -> Overweight
2022-10-20HC Wainwright & Co.Maintains Buy
2022-09-26WedbushMaintains Outperform
2022-09-07Capital OneInitiate Overweight
2021-06-03HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.01
Revenue Estimate
15.304M
Revenue Q2Q
74.88%
EPS Q2Q
70.24%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
-12.90%
Revenue (3 Months)
-12.90%
EPS (1 Month)
-111.67%
EPS (3 Months)
-111.67%

Next Earnings Summary

FENC is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.01 USD and the consensus revenue estimate is 15.30M USD.
The next earnings revenue estimate has been revised downward by 12.9% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
FENC revenue by date.FENC revenue by date.
21.252M
1,280.00%		47.538M
123.69%		44.642M
-6.09%		73.715M
65.12%		104M
41.08%		138.32M
33.00%		199.52M
44.25%		217.38M
8.95%		197.72M
-9.04%		200.55M
1.43%		151.86M
-24.28%
EBITDA
YoY % growth
FENC ebitda by date.FENC ebitda by date.
N/AN/A
216.67%		N/A
-69.29%		30.345M
1,283.72%		33.864M
11.60%		52.887M
56.17%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
FENC ebit by date.FENC ebit by date.
-12.771M
43.47%		2.568M
120.11%		-6.282M
-344.63%		22.1M
451.80%		35.625M
61.20%		61.455M
72.51%		112.85M
83.63%		120.25M
6.56%		116.7M
-2.95%		123.47M
5.80%		81.539M
-33.96%
Operating Margin
FENC operating margin by date.FENC operating margin by date.
-60.09%5.40%-14.07%29.98%34.25%44.43%56.56%55.32%59.02%61.57%53.69%
EPS
YoY % growth
FENC eps by date.FENC eps by date.
-0.61
32.22%		0.00
100.00%		-0.27
-486,388,759,756,013,500.00%		0.43
259.30%		1.09
153.75%		1.53
39.95%		2.83
85.20%		2.85
0.84%		2.26
-20.80%		2.07
-8.58%		0.90
-56.30%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.01
70.24%		0.15
236.00%		0.09
550.48%		0.17
268.30%		0.15
1,385.35%		0.20
36.36%		0.24
171.71%		0.56
233.33%
Revenue
Q2Q % growth		15.304M
74.88%		19.069M
97.57%		19.074M
53.06%		21.687M
57.41%		18.951M
23.83%		19.981M
4.78%		21.379M
12.08%		27.407M
26.38%
EBITDA
Q2Q % growth		510K
138.46%		15.606M
1,600.00%		7.548M
208.33%		14.28M
218.18%		7.752M
1,420.00%		9.384M
-39.87%		10.812M
43.24%		21.93M
53.57%
EBIT
Q2Q % growth		-1.12M
-38.67%		5.787M
311.82%		3.625M
2,017.99%		7.053M
376.16%		5.61M
600.68%		7.242M
25.14%		8.772M
141.99%		19.89M
182.01%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

FENC Yearly Revenue VS EstimatesFENC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
FENC Yearly EPS VS EstimatesFENC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
97.10%
EPS Next 5 Year
65.90%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
44.38%
Revenue Next 5 Year
36.45%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
212.19%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FENNEC PHARMACEUTICALS INC / FENC Forecast FAQ

What is the price target for FENC stock?

13 analysts have analysed FENC and the average price target is 15.47 USD. This implies a price increase of 132.98% is expected in the next year compared to the current price of 6.64.

Can you provide the upcoming earnings date for FENNEC PHARMACEUTICALS INC?

FENNEC PHARMACEUTICALS INC (FENC) will report earnings on 2026-05-07.

Can you provide the consensus estimates for FENNEC PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of FENNEC PHARMACEUTICALS INC (FENC) is -0.01 USD and the consensus revenue estimate is 15.30M USD.

How many analysts cover FENNEC PHARMACEUTICALS INC (FENC) stock?

The number of analysts covering FENNEC PHARMACEUTICALS INC (FENC) is 13.